| European Medicines Agency review of post-authorisation studies with implications for the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance. | |
| | |
MedLine Citation:
|
PMID: 22039593 Owner: NLM Status: In-Process |
Abstract/OtherAbstract:
|
PURPOSE: A review of post-authorisation studies requested in 2007 by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) was undertaken to determine compliance and the need for research capacity in the European Union (EU), with implications for the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP). METHODS: Information from the EMA's electronic records management systems was analysed. RESULTS: As of 31 January 2010, of the 60 relevant studies identified, 52 had been progressed to being able to start data collection (including six merged into a single study). Of the remaining eight studies, the agreement of the CHMP that a proposed study was no longer required is documented for six, with a final decision having not been reached for another study and an acknowledgement by the CHMP that a further study would not be progressed. Of the 47 studies that could therefore have commenced data collection or extraction, 38 were ongoing, four were complete and five had not yet started. Most studies were conducted within the EU. CONCLUSION: Compliance with the request of the CHMP to conduct studies is very good. The review identified the need for careful consideration of the necessity of studies and of timely dialogue on protocols in advance of a CHMP opinion. The need for expertise and capacity within the EU for the conduct of post-authorisation studies is confirmed. ENCePP as a transparency and excellence network and as an initiative to build research capacity will enhance post-authorisation medicines research. |
| | |
Authors:
|
Kevin V Blake; Stefanie Prilla; Sophie Accadebled; Marie Guimier; Monica Biscaro; Ingemar Persson; Peter Arlett; Stella Blackburn; Henry Fitt |
Related Documents
:
|
22230833 - Systematic review and meta-analysis of practice facilitation within primary care settings. 3088693 - Prescribed daily dose of phenoxymethylpenicillin in general practice. 2703893 - Manager impact on retention of hospital staff: part 2. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Pharmacoepidemiology and drug safety Volume: 20 ISSN: 1099-1557 ISO Abbreviation: Pharmacoepidemiol Drug Saf Publication Date: 2011 Oct |
Date Detail:
|
Created Date: 2011-10-28 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9208369 Medline TA: Pharmacoepidemiol Drug Saf Country: England |
Other Details:
|
Languages: eng Pagination: 1021-9 Citation Subset: IM |
Affiliation:
|
Pharmacovigilance and Risk Management Sector, Patient Health Protection Unit, European Medicines Agency, London, UK. kevin.blake@ema.europa.eu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Exploiting nature's rich source of proteasome inhibitors as starting points in drug development.
Next Document: Major bleeding risk associated with warfarin and co-medications in the elderly population.